biontech/pfizer’s bnt162b2 mrna vaccine (BioNTech)
90
Structured Review
BioNTech
biontech/pfizer’s bnt162b2 mrna vaccine
Biontech/Pfizer’s Bnt162b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+vaccine+bnt162b2/bnt162b2/pm40333307-304-8-7
Average 90 stars, based on 1 article reviews
Biontech/Pfizer’s Bnt162b2 Mrna Vaccine, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer-biontech+vaccine+bnt162b2/bnt162b2/pm40333307-304-8-7
Average 90 stars, based on 1 article reviews
biontech/pfizer’s bnt162b2 mrna vaccine - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Neutralization:Article Title: A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75. Article Snippet: Neutralization assays were performed using serumobtained 28 days following a third dose of theOxford-AstraZeneca vaccine AZD1222 (n = 41)23 or of Article Title: Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18 F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine Article Snippet: Nevertheless, most of the published studies focus on PET findings after mRNA COVID-19 vaccine; these studies originate from countries outside Asia, except for one study in Korea, which included ChAdOx1, and one study in Japan which included Article Title: Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2 Article Snippet: Firstly, the neutralisation profile with sera collected 4 weeks following a third dose of the Oxford-AstraZeneca vaccine AZD1222 (n=41) or Article Title: Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2 Article Snippet: Firstly, the neutralisation profile was examined with sera collected 4 weeks following a third dose of the Article Title: Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy Article Snippet: Neutralisation assays were performed using Article Title: COVID-19 vaccination among different types of US Healthcare Personnel. Article Snippet: Four vaccines against Coronavirus Disease 2019 (COVID-19) have been authorized by the United States (US) Food and Drug Administration (FDA): the Article Title: Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18 F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine. Article Snippet: Nevertheless, most of the published studies focus on PET findings after mRNA COVID-19 vaccine; these studies originate from countries outside Asia, except for one study in Korea, which included ChAdOx1, and one study in Japan which included Article Title: Atomic Insights into pH-Dependent and Water Permeation of mRNA-Lipid Nanoparticles. Article Snippet: The exposure of mRNA to water is likely to contribute to the instability of RNA vaccines upon storage under nonfrozen conditions.. Using atomistic molecular dynamics (MD) simulations, we investigated the pH-dependent structural transition and water penetration behavior of mRNA-lipid nanoparticles (LNPs) with the compositions of Moderna and Pfizer vaccines against COVID-19 in an aqueous solution.. It was revealed that the ionizable lipid (IL) membranes of LNPs were extremely sensitive to pH, and the increased acidity could cause a rapid membrane collapse and hydration swelling of LNP, confirming the high releasing efficiency of both LNP vaccines. |